582
Views
3
CrossRef citations to date
0
Altmetric
REVIEW

Latest Trends in Retinopathy of Prematurity: Research on Risk Factors, Diagnostic Methods and Therapies

, , , , ORCID Icon, , ORCID Icon, , , ORCID Icon & show all
Pages 937-949 | Received 12 Dec 2022, Accepted 17 Feb 2023, Published online: 14 Mar 2023

References

  • Wood EH, Chang EY, Beck K, Hadfield BR, Quinn AR, Harper CA. 80 Years of vision: preventing blindness from retinopathy of prematurity. J Perinatol. 2021;41(6):1216–1224. doi:10.1038/s41372-021-01015-8
  • Sen P, Wu WC, Chandra P, Vinekar A, Manchegowda PT, Bhende P. Retinopathy of prematurity treatment: asian perspectives. Eye. 2020;34(4):632–642. doi:10.1038/s41433-019-0643-4
  • Akkawi MT, Shehadeh MM, Shams ANA, et al. Incidence and risk factors of retinopathy of prematurity in three neonatal intensive care units in Palestine. BMC Ophthalmol. 2019;19(1):189. doi:10.1186/s12886-019-1180-4
  • Freitas AM, Mörschbächer R, Thorell MR, Rhoden EL. Incidence and risk factors for retinopathy of prematurity: a retrospective cohort study. Int J Retina Vitreous. 2018;4(1):20. doi:10.1186/s40942-018-0125-z
  • Chow SC, Lam PY, Lam WC, Fung NSK. The role of anti-vascular endothelial growth factor in treatment of retinopathy of prematurity-a current review. Eye. 2022;36(8):1532–1545. doi:10.1038/s41433-021-01922-2
  • Ramshekar A, Hartnett ME. Vascular endothelial growth factor signaling in models of oxygen-induced retinopathy: insights into mechanisms of pathology in retinopathy of prematurity. Front Pediatr. 2021;9:796143. doi:10.3389/fped.2021.796143
  • Satnarine T, Lee Kin C-M, Kevin L. Retinopathy of prematurity: a review of risk factors, oxygen targets, screening criteria. J Med Health Studies. 2015;3(2):26–36. doi:10.32996/jmhs.2022.3.2.5
  • Shah PK, Prabhu V, Karandikar SS, Ranjan R, Narendran V, Kalpana N. Retinopathy of prematurity: past, present and future. World J Clin Pediatr. 2016;5(1):35–46. doi:10.5409/wjcp.v5.i1.35
  • Brown AC, Nwanyanwu K. Retinopathy of Prematurity. Treasure Island (FL): StatPearls Publishing; 2022.
  • Eckert GU, Fortes Filho JB, Maia M, Procianoy RS. A predictive score for retinopathy of prematurity in very low birth weight preterm infants. Eye. 2012;26(3):400–406. doi:10.1038/eye.2011.334
  • Cooper JS, Phuyal P, Shah N. Oxygen Toxicity. Treasure Island (FL): StatPearls Publishing; 2022.
  • Chang M. Optimal oxygen saturation in premature infants. Korean J Pediatr. 2011;54(9):359–362. doi:10.3345/kjp.2011.54.9.359
  • Hartnett ME, Lane RH. Effects of oxygen on the development and severity of retinopathy of prematurity. J AAPOS. 2013;17(3):229–234. doi:10.1016/j.jaapos.2012.12.155
  • Pastro J, Toso BRGO. Influence of oxygen in the development of retinopathy of prematurity. Rev Bras Enferm. 2019;72(3):592–599. doi:10.1590/0034-7167-2018-0361
  • Cayabyab R, Ramanathan R. Retinopathy of prematurity: therapeutic strategies based on pathophysiology. Neonatology. 2016;109(4):369–376. doi:10.1159/000444901
  • Higgins RD. Oxygen saturation and retinopathy of prematurity. Clin Perinatol. 2019;46(3):593–599. doi:10.1016/j.clp.2019.05.008
  • Cayabyab R, Arora V, Wertheimer F, Durand M, Ramanathan R. Graded oxygen saturation targets and retinopathy of prematurity in extremely preterm infants. Pediatr Res. 2016;80(3):401–406. doi:10.1038/pr.2016.98
  • Jafari N, Karimi Moghadam A, Taslimi Taleghani N, Hosseini Nezhad N, Motamed N, Jalilvand A. How is insulin-like growth factor-1 correlated with retinopathy of prematurity? J Res Med Sci. 2021;26(1):111. doi:10.4103/jrms.JRMS_501_20
  • Clatici VC, Georgescu O, Draganita AMV, et al. Milk and insulin growth factor 1 (IGF1) – implication in acne and general health. Rom Biotechnol Lett. 2015;20:10013–10025. doi:10.1016/j.earlhumdev.2016.09.008
  • Tan W, Li B, Wang Z, et al. Novel potential biomarkers for retinopathy of prematurity. Front Med. 2022;9:840030.
  • Hård AL, Smith LE, Hellström A. Nutrition, insulin-like growth factor-1 and retinopathy of prematurity. Semin Fetal Neonatal Med. 2013;18(3):136–142. doi:10.1016/j.siny.2013.01.006
  • Liegl R, Löfqvist C, Hellström A, Smith LE. IGF-1 in retinopathy of prematurity, a CNS neurovascular disease. Early Hum Dev. 2016;102:13–19.
  • Pérez-Muñuzuri A, Fernández-Lorenzo JR, Couce-Pico ML, Blanco-Teijeiro MJ, Fraga-Bermúdez JM. Serum levels of IGF1 are a useful predictor of retinopathy of prematurity. Acta Paediatr. 2010;99(4):519–525. doi:10.1111/j.1651-2227.2009.01677.x
  • Gharehbaghi MM, Peirovifar A, Sadeghi K, Mostafidi H. Insulin-like growth factor binding protein-3 in preterm infants with retinopathy of prematurity. Indian J Ophthalmol. 2012;60(6):527–530. doi:10.4103/0301-4738.103782
  • Zhang HB, Wang XD, Xu K, Li XG. The progress of prophylactic treatment in retinopathy of prematurity. Int J Ophthalmol. 2018;11(5):858–873. doi:10.18240/ijo.2018.05.24
  • Eroglu SA, Unsal AIA, Abdullayev OK, et al. The role of hepatic and renal functions in the development of retinopathy of prematurity: is proteinuria a new risk factor? Int Ophthalmol. 2022. doi:10.1007/s10792-022-02445-9
  • Gao Q, Lu C, Tian X, Zheng J, Ding F. Urine podocyte mRNA loss in preterm infants and related perinatal risk factors. Pediatr Nephrol. 2023;38(3):729–738. doi:10.1007/s00467-022-05663-6
  • Abbas K, Lu Y, Bavishi S, et al. A simple review of small vessel disease manifestation in the brain, retina, and kidneys. J Clin Med. 2022;11(19):5546. doi:10.3390/jcm11195546
  • Sangla A, Kandasamy Y. Effects of prematurity on long-term renal health: a systematic review. BMJ Open. 2021;11(8):e047770. doi:10.1136/bmjopen-2020-047770
  • Ponthier L, Trigolet M, Chianea T, et al. Distribution of proteinuria- and albuminuria-to-creatinine ratios in preterm newborns. Pediatr Nephrol. 2021;36(6):1515–1524. doi:10.1007/s00467-020-04838-3
  • Soto Conti CP. Bilirubin: the toxic mechanisms of an antioxidant molecule. Bilirrubina: mecanismos tóxicos de una molécula antioxidante. Arch Argent Pediatr. 2021;119(1):e18–e25. doi:10.5546/aap.2021.eng.e18
  • Boskabadi H, Shoeibi N, Bagheri F, Pourbadakhshan N, Moradi A, Zakerihamidi M. Potential role of bilirubin in preventing retinopathy of prematurity [published online ahead of print, 2022 Aug 19]. Curr Pediatr Rev. 2022. doi:10.2174/1573396318666220819151154
  • Chang JW. Risk factor analysis for the development and progression of retinopathy of prematurity. PLoS One. 2019;14(7):e0219934. doi:10.1371/journal.pone.0219934
  • Vähätupa M, Järvinen TAH, Uusitalo-Järvinen H. Exploration of oxygen-induced retinopathy model to discover new therapeutic drug targets in retinopathies. Front Pharmacol. 2020;11:873. doi:10.3389/fphar.2020.00873
  • Sonny S, Yuan H, Chen S, et al. GSDMD deficiency ameliorates hyperoxia-induced BPD and ROP in neonatal mice. Sci Rep. 2023;13(1):143. doi:10.1038/s41598-022-27201-y
  • Gomaa N, El-Shewy A. Relationship between retinopathy of prematurity (ROP) and bronchopulmonary dysplasia (BPD): a retrospective-analytical study. Ann Neonatol J. 2022;4(1):45–70. doi:10.21608/anj.2021.100450.1038
  • Tiffani WT, Rao R, Gu H, Lee A, Reynolds M. Retinopathy of prematurity: risk stratification by gestational age. J Perinatol. 2023. doi:10.1038/s41372-023-01604-9
  • Noor MS, Elbarbary M, Embabi SN, Zaki MA, Awad H, Al-Feky M. Screening and risk factors for retinopathy of prematurity in a tertiary care hospital in Cairo, Egypt. Clin Ophthalmol. 2022;16:3257–3267. doi:10.2147/OPTH.S383493
  • Lucchesi M, Marracci S, Amato R, Filippi L, Cammalleri M, Dal Monte M. Neurosensory alterations in retinopathy of prematurity: a window to neurological impairments associated to preterm birth. Biomedicines. 2022;10(7):1603. doi:10.3390/biomedicines10071603
  • Soares Reis J, Pereira A, et al. Intraventricular hemorrhage in preterm infants: risk factors and neurodevelopmental outcomes. J Pediatric Neonatal Individualized Med. 2023;12(1):e120118. doi:10.7363/120118
  • Reich B, Hoeber D, Bendix I, Felderhoff-Mueser U. Hyperoxia and the immature brain. Dev Neurosci. 2016;38(5):311–330. doi:10.1159/000454917
  • Morken TS, Dammann O, Skranes J, Austeng D. Retinopathy of prematurity, visual and neurodevelopmental outcome, and imaging of the central nervous system. Semin Perinatol. 2019;43(6):381–389. doi:10.1053/j.semperi.2019.05.012
  • Stutchfield CJ, Jain A, Odd D, Williams C, Markham R. Foetal haemoglobin, blood transfusion, and retinopathy of prematurity in very preterm infants: a pilot prospective cohort study. Eye. 2017;31(10):1451–1455. doi:10.1038/eye.2017.76
  • Lin L, Binenbaum G. Postnatal weight gain and retinopathy of prematurity. Semin Perinatol. 2019;43(6):352–359. doi:10.1053/j.semperi.2019.05.008
  • Zhu Z, Hua X, Yu Y, Zhu P, Hong K, Ke Y. Effect of red blood cell transfusion on the development of retinopathy of prematurity: a systematic review and meta-analysis. PLoS One. 2020;15(6):e0234266. doi:10.1371/journal.pone.0234266
  • Pheng E, Lim ZD. Haemoglobin levels in early life among infants with and without retinopathy of prematurity. Int J Environ Res Public Health. 2021;18(13):7054. doi:10.3390/ijerph18137054
  • Wilson CM, Ells AL, Fielder AR. The challenge of screening for retinopathy of prematurity. Clin Perinatol. 2013;40(2):241–259. doi:10.1016/j.clp.2013.02.003
  • Piermarocchi S, Bini S, Martini F, et al. Predictive algorithms for early detection of retinopathy of prematurity. Acta Ophthalmol. 2017;95(2):158–164. doi:10.1111/aos.13117
  • Hartnett ME. Advances in understanding and management of retinopathy of prematurity. Surv Ophthalmol. 2017;62(3):257–276. doi:10.1016/j.survophthal.2016.12.004
  • Pivodic A, Johansson H, Smith LEH, et al. Development and validation of a new clinical decision support tool to optimize screening for retinopathy of prematurity. Br J Ophthalmol. 2022;106(11):1573–1580. doi:10.1136/bjophthalmol-2020-318719
  • Pivodic A, Smith EH. Validation of DIGIROP models and decision support tool for prediction of treatment for retinopathy of prematurity on a contemporary Swedish cohort. Br J Ophthalmol. 2022. doi:10.1136/bjophthalmol-2021-320738
  • Zin A, Gole GA. Retinopathy of prematurity-incidence today. Clin Perinatol. 2013;40(2):185–200. doi:10.1016/j.clp.2013.02.001
  • Chiang MF, Quinn GE, Fielder AR, et al. International Classification of Retinopathy of Prematurity, Third Edition. Ophthalmology. 2021;128(10):e51–e68. doi:10.1016/j.ophtha.2021.05.031
  • Fierson WM, Chiang MF, Good W, et al. AMERICAN ACADEMY OF PEDIATRICS Section on Ophthalmology; AMERICAN ACADEMY OF OPHTHALMOLOGY; AMERICAN ASSOCIATION FOR PEDIATRIC OPHTHALMOLOGY AND STRABISMUS; AMERICAN ASSOCIATION OF CERTIFIED ORTHOPTISTS. Screening examination of premature infants for retinopathy of prematurity. Pediatrics. 2018;142(6):e20183061. doi:10.1542/peds.2018-3061
  • Tan Z, Chong C, Darlow B, Dai S. Visual impairment due to retinopathy of prematurity (ROP) in New Zealand: a 22-year review. Br J Ophthalmol. 2015;99(6):801–806. doi:10.1136/bjophthalmol-2014-305913
  • Royal College of Paediatrics and Child Health. UK screening of retinopathy of prematurity guideline: summary of recommendations; 2022.
  • Shukla R, Murthy GVS, Gilbert C, Vidyadhar B, Mukpalkar S. Operational guidelines for ROP in India: a summary. Indian J Ophthalmol. 2020;68(13):S108–S114. doi:10.4103/ijo.IJO_1827_19
  • Fierson WM, Saunders RA, Good W, et al. American Academy of Pediatrics Section on Ophthalmology; American Academy of Ophthalmology; American Association for Pediatric Ophthalmology and Strabismus; American Association of Certified Orthoptists. Screening examination of premature infants for retinopathy of prematurity. Pediatrics. 2013;131(1):189–195. doi:10.1542/peds.2012-2996
  • Bashinsky AL. Retinopathy of Prematurity. N C Med J. 2017;78(2):124–128. doi:10.18043/ncm.78.2.124
  • Berrocal AM, Fan KC, Al-Khersan H, Negron CI, Murray T. Retinopathy of Prematurity: advances in the Screening and Treatment of Retinopathy of Prematurity Using a Single Center Approach. Am J Ophthalmol. 2022;233:189–215. doi:10.1016/j.ajo.2021.07.016
  • Beck K, Young R, Read S, Harper H, Desireddi J, Harper CA. The severity and associated comorbidities of retinopathy of prematurity among micro-premature infants with birth weights less than 750 grams. J Neonatal Perinatal Med. 2019;12(1):41–45. doi:10.3233/NPM-17158
  • Dogra MR, Katoch D, Dogra M. An update on retinopathy of prematurity (ROP). Indian J Pediatr. 2017;84(12):930–936. doi:10.1007/s12098-017-2404-3
  • Wang J, Chen F, He S, Xiang D. Screening retinopathy of prematurity in extremely low birth weight infants in china and the need for earlier screening times. J Ophthalmol. 2016;2016:7065835. doi:10.1155/2016/7065835
  • Thanos A, Yonekawa Y, Todorich B, Moshfeghi DM, Trese MT. Screening and treatments using telemedicine in retinopathy of prematurity. Eye Brain. 2016;8:147–151. doi:10.2147/EB.S94440
  • Karkhaneh R, Ahmadraji A, Riazi Esfahani M, et al. The accuracy of digital imaging in diagnosis of retinopathy of prematurity in Iran: a pilot study. J Ophthalmic Vis Res. 2019;14(1):38–41. doi:10.4103/jovr.jovr_187_17
  • Wang J, Liu C, Wu H, Ng TK, Zhang M. Diagnostic accuracy of wide-field digital retinal images in retinopathy of prematurity detection: systematic review and meta-analysis. CurrEye Res. 2022;47(7):1024–1033. doi:10.1080/02713683.2022.2050262
  • Bao Y, Ming WK, Mou ZW, et al. Current application of digital diagnosing systems for retinopathy of prematurity. Comput Methods Programs Biomed. 2021;200:105871. doi:10.1016/j.cmpb.2020.105871
  • Moraru AD, Costin D, Moraru RL, Branisteanu DC. Artificial intelligence and deep learning in ophthalmology - present and future (Review). [Review]. Exp Ther Med. 2020;20(4):3469–3473. doi:10.3892/etm.2020.9118
  • Scruggs BA, Chan RVP, Kalpathy-Cramer J, Chiang MF, Campbell JP. Artificial intelligence in retinopathy of prematurity diagnosis. Transl Vis Sci Technol. 2020;9(2):5. doi:10.1167/tvst.9.2.5
  • Benet D, Pellicer-Valero OJ. Artificial intelligence: the unstoppable revolution in ophthalmology. Surv Ophthalmol. 2022;67(1):252–270. doi:10.1016/j.survophthal.2021.03.003
  • Li JO, Liu H, Ting DSJ, et al. Digital technology, tele-medicine and artificial intelligence in ophthalmology: a global perspective. Prog Retin Eye Res. 2021;82:100900. doi:10.1016/j.preteyeres.2020.100900
  • Wu Q, Hu Y, Mo Z, et al. Development and validation of a deep learning model to predict the occurrence and severity of retinopathy of prematurity. JAMA Netw Open. 2022;5(6):e2217447. doi:10.1001/jamanetworkopen.2022.17447
  • Campbell JP, Chiang MF, Chen JS, et al. Artificial intelligence for retinopathy of prematurity: validation of a vascular severity scale against international expert diagnosis. Ophthalmology. 2022;129(7):e69–e76. doi:10.1016/j.ophtha.2022.02.008
  • Ramanathan A, Athikarisamy SE, Lam GC. Artificial intelligence for the diagnosis of retinopathy of prematurity: a systematic review of current algorithms. Eye. 2022. doi:10.1038/s41433-022-02366-y
  • Brown JM, Campbell JP, Beers A, et al. Imaging and Informatics in Retinopathy of Prematurity (i-ROP) Research Consortium. Automated diagnosis of plus disease in retinopathy of prematurity using deep convolutional neural networks. JAMA Ophthalmol. 2018;136(7):803–810. doi:10.1001/jamaophthalmol.2018.1934
  • Attallah O. DIAROP: automated deep learning-based diagnostic tool for retinopathy of prematurity. Diagnostics. 2021;11(11):2034. doi:10.3390/diagnostics11112034
  • Sharma A, Subramaniam SD, Ramachandran KI, Lakshmikanthan C, Krishna S, Sundaramoorthy SK. Smartphone-based fundus camera device (MII Ret Cam) and technique with ability to image peripheral retina. Eur J Ophthalmol. 2016;26(2):142–144. doi:10.5301/ejo.5000663
  • Lin JY, Kang EY, Banker AS, et al. Comparison of RetCam and smartphone-based photography for retinopathy of prematurity screening. Diagnostics. 2022;12(4):945. doi:10.3390/diagnostics12040945
  • Shah PK, Ramya A, Narendran V. Telemedicine for ROP. Asia Pac J Ophthalmol. 2018;7(1):52–55. doi:10.22608/APO.2017478
  • Vinekar A, Gilbert C, Dogra M, et al. The KIDROP model of combining strategies for providing retinopathy of prematurity screening in underserved areas in India using wide-field imaging, tele-medicine, non-physician graders and smart phone reporting. Indian J Ophthalmol. 2014;62(1):41–49. doi:10.4103/0301-4738.126178
  • Daniel E, Quinn GE, Hildebrand PL, et al.; e-ROP Cooperative Group. Validated system for centralized grading of retinopathy of prematurity: Telemedicine approaches to Evaluating Acute-Phase Retinopathy of Prematurity (e-ROP) Study. JAMA Ophthalmol. 2015;133(6):675–682. doi:10.1001/jamaophthalmol.2015.0460
  • Vinekar A, Mangalesh S, Jayadev C, Gilbert C, Dogra M, Shetty B. Impact of expansion of telemedicine screening for retinopathy of prematurity in India. Indian J Ophthalmol. 2017;65(5):390–395. doi:10.4103/ijo.IJO_211_17
  • Hložánek M, Straňák Z, Terešková Z, Mareš J, Krejčířová I, Česká Burdová M. Trends in neonatal ophthalmic screening methods. Diagnostics. 2022;12(5):1251. doi:10.3390/diagnostics12051251
  • Chen X, Mangalesh S, Dandridge A, et al. Spectral-domain OCT findings of retinal vascular-avascular junction in infants with retinopathy of prematurity. Ophthalmol Retina. 2018;2(9):963–971. doi:10.1016/j.oret.2018.02.001
  • Valikodath N, Cole E, Chiang MF, Campbell JP, Chan RVP. Imaging in retinopathy of prematurity. Asia Pac J Ophthalmol. 2019;8(2):178–186. doi:10.22608/APO.201963
  • Scruggs BA, Ni S, Nguyen TP, et al. Peripheral OCT assisted by scleral depression in retinopathy of prematurity. Ophthalmol Sci. 2022;2(1):100094. doi:10.1016/j.xops.2021.100094
  • Liegl R, Hellström A, Smith LE. Retinopathy of prematurity: the need for prevention. Eye Brain. 2016;8:91–102. doi:10.2147/EB.S99038
  • Acar DE, Acar U, Tunay ZO, Arman A, Barak A. Effects of diode laser photocoagulation treatment on ocular biometric parameters in premature infants with retinopathy of prematurity. Int J Ophthalmol. 2021;14(2):277–282. doi:10.18240/ijo.2021.02.15
  • Arima M, Fujii Y, Sonoda KH. Translational research in retinopathy of prematurity: from bedside to bench and back again. J Clin Med. 2021;10(2):331. doi:10.3390/jcm10020331
  • Nicoară SD. Indirect diode laser in the treatment of retinopathy of prematurity. IntechOpen Laser Technol Appl. 2018;6:107–121. doi:10.5772/intechopen.79828
  • Sen P, Agarwal AAK, Bhende P, Ganesan S. Treatment outcomes of combination of anti-vascular endothelial growth factor injection and laser photocoagulation in Type 1 ROP and APROP. Int Ophthalmol. 2022;42(1):95–101. doi:10.1007/s10792-021-02004-8
  • Sankar MJ, Sankar J, Chandra P. Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity. Cochrane Database Syst Rev. 2018;1(1):CD009734. doi:10.1002/14651858.CD009734.pub3
  • Patel JR, Ranjan SS, Wasserman BN. Antivascular endothelial growth factor in the treatment of retinopathy of prematurity. Curr Opin Ophthalmol. 2016;27(5):387–392. doi:10.1097/ICU.0000000000000286
  • Xu C, Zhang H, Zhong W, Zhou H. The role of connexin in ophthalmic neovascularization and the interaction between connexin and proangiogenic factors. J Ophthalmol. 2022;2022:8105229. doi:10.1155/2022/8105229
  • Ryu J. New aspects on the treatment of retinopathy of prematurity: currently available therapies and emerging novel therapeutics. Int J Mol Sci. 2022;23(15):8529. doi:10.3390/ijms23158529
  • Autrata R, Krejcírová I, Senková K, Holoušová M, Doležel Z, Borek I. Intravitreal pegaptanib combined with diode laser therapy for stage 3+ retinopathy of prematurity in zone I and posterior zone II. Eur J Ophthalmol. 2012;22(5):687–694. doi:10.5301/ejo.5000166
  • Süren E, Özkaya D, Çetinkaya E, et al. Comparison of bevacizumab, ranibizumab and aflibercept in retinopathy of prematurity treatment. Int Ophthalmol. 2022;42(6):1905–1913. doi:10.1007/s10792-021-02188-z
  • Huang CY, Lien R, Wang NK, et al. Changes in systemic vascular endothelial growth factor levels after intravitreal injection of aflibercept in infants with retinopathy of prematurity. GraefesArch Clin Exp Ophthalmol. 2018;256(3):479–487. doi:10.1007/s00417-017-3878-4
  • Semeraro F, Morescalchi F, Duse S, Parmeggiani F, Gambicorti E, Costagliola C. Aflibercept in wet AMD: specific role and optimal use. Drug Des Devel Ther. 2013;7:711–722. doi:10.2147/DDDT.S40215
  • Chen P-Y (Jay), Rossin EJ, Vavvas DG. Aflibercept for retinopathy of prematurity: a systematic review and meta-analysis. Ophthalmic Surg Lasers Imaging Retina. 2021;52(12):673–681. doi:10.3928/23258160-20211124-01
  • Vedantham V. Intravitreal aflibercept injection in Indian eyes with retinopathy of prematurity. Indian J Ophthalmol. 2019;67(6):884–888. doi:10.4103/ijo.IJO_708_18
  • Stahl A, Lepore D, Fielder A, et al. Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial. Lancet. 2019;394(10208):1551–1559. doi:10.1016/S0140-6736(19)31344-3
  • Pertl L, Steinwender G, Mayer C, et al. A systematic review and meta-analysis on the safety of vascular endothelial growth factor (VEGF) inhibitors for the treatment of retinopathy of prematurity. PLoS One. 2015;10(6):e0129383. doi:10.1371/journal.pone.0129383
  • Beccasio A, Mignini C, Caricato A, et al. New trends in intravitreal anti-VEGF therapy for ROP. Eur J Ophthalmol. 2022;32(3):1340–1351. doi:10.1177/11206721211073405
  • Hwang CK, Hubbard GB, Hutchinson AK, Lambert SR. Outcomes after intravitreal bevacizumab versus laser photocoagulation for retinopathy of prematurity: a 5-year retrospective analysis. Ophthalmology. 2015;122(5):1008–1015. doi:10.1016/j.ophtha.2014.12.017
  • Chiang MC, Chen YT, Kang EY, et al. Neurodevelopmental outcomes for retinopathy of prematurity: a Taiwan premature infant follow-up network database study. Am J Ophthalmol. 2022;247:170–180. doi:10.1016/j.ajo.2022.10.020
  • Tsang JKW, Liu J, Lo ACY. Vascular and neuronal protection in the developing retina: potential therapeutic targets for retinopathy of prematurity. Int J Mol Sci. 2019;20(17):4321. doi:10.3390/ijms20174321
  • Stahl A, Hellstrom A, Smith LE. Insulin-like growth factor-1 and anti-vascular endothelial growth factor in retinopathy of prematurity: has the time come? Neonatology. 2014;106(3):254–260. doi:10.1159/000365132
  • Good WV, Hardy RJ, Wallace DK, et al. β-Blocking and racial variation in the severity of retinopathy of prematurity. Arch Ophthalmol. 2012;130(1):117–118. doi:10.1001/archopht.130.1.117
  • Filippi L, Cammalleri M, Amato R, et al. Decoupling oxygen tension from retinal vascularization as a new perspective for management of retinopathy of prematurity. New opportunities from β-adrenoceptors. Front Pharmacol. 2022;13:835771. doi:10.3389/fphar.2022.835771
  • Cavallaro G, Filippi L, Bagnoli P, et al. The pathophysiology of retinopathy of prematurity: an update of previous and recent knowledge. Acta Ophthalmol. 2014;92(1):2–20. doi:10.1111/aos.12049
  • Kondo H, Kusaka S, Yoshinaga A, Uchio E, Tawara A, Tahira T. Genetic variants of FZD4 and LRP5 genes in patients with advanced retinopathy of prematurity. Mol Vis. 2013;19:476–485.
  • Hiraoka M, Takahashi H, Orimo H, Hiraoka M, Ogata T, Azuma N. Genetic screening of Wnt signaling factors in advanced retinopathy of prematurity. Mol Vis. 2010;16:2572–2577.
  • Ortega-Molina JM, Anaya-Alaminos R, Uberos-Fernández J, et al. Genetic and environmental influences on retinopathy of prematurity. Mediators Inflamm. 2015;2015:764159. doi:10.1155/2015/764159
  • Fevereiro-Martins M, Guimarães H, Marques-Neves C, Bicho M. Retinopathy of prematurity: contribution of inflammatory and genetic factors. Mol Cell Biochem. 2022;477(6):1739–1763. doi:10.1007/s11010-022-04394-4